Biotechnology Insurance

Biotech insurance, like the biotech industry, is enjoying transformative breakthroughs across medicine, agriculture, and beyond. Just as this industry grafts tech and biology, Relm combines expertise in insurance and emerging industries to build custom biotechnology insurance solutions that safeguard against risks. Whether developing new therapies or scaling operations, our biotech insurance services give companies confidence to innovate sustainably.

Biotech Coverage Built for Innovators

Biotechnology Insurance Risks

01

Clinical Trial Liabilities

Testing new therapies comes with risks, from participant safety concerns to trial disruptions. Clinical trials can face unanticipated adverse reactions from participants, potentially leading to costly lawsuits or delays in regulatory approval. Another issue is data integrity — researchers mishandling data can invalidate results and delay market access. Our biotech insurance services provide thoughtful coverage to support these critical processes.
02

Intellectual Property Disputes

The biotech industry is fueled by innovation, making IP protection essential. Instances like patent infringement can arise from competing companies claiming rights to the same molecule or treatment method. Additionally, data and trade secrets may be stolen or leaked via employees or hackers, leading to financial and reputational harm. We help companies bolster their breakthroughs with biotechnology insurance designed to address such disputes.
03

Product Liability Claims

From new treatments to biopharma products, unforeseen outcomes can lead to liability exposures. Examples can include failure of medical devices like implanted pacemakers, leading to personal injury and financial loss. Relm’s insurance for biotech companies fortifies every stage of the product lifecycle.
04

mRNA Technology Safety Liabilities

mRNA technology, which powers vaccines and other therapies, presents innovative breakthroughs — but with them come distinct safety liabilities. Adverse reactions or long-term side effects not predicted in clinical trials can expose companies to legal and financial risks. We offer biotech insurance that’s specifically designed to cover the evolving liabilities tied to mRNA-based treatments, ensuring your innovation is protected.